A classical view of blood cell development is that multipotent hematopoietic stem and progenitor cells (HSPCs) become lineage-restricted at defined stages. Lin−c-Kit+Sca-1+Flt3+ cells, termed lymphoid-primed multipotent progenitors (LMPPs), have lost megakaryocyte and erythroid potential but are heterogeneous in their fate. Here, through single-cell RNA sequencing, we identify the expression of Dach1 and associated genes in this fraction as being coexpressed with myeloid/stem genes but inversely correlated with lymphoid genes. Through generation of Dach1–GFP reporter mice, we identify a transcriptionally and functionally unique Dach1–GFP− subpopulation within LMPPs with lymphoid potential with low to negligible classic myeloid potential. We term these ‘lymphoid-primed progenitors’ (LPPs). These findings define an early definitive branch point of lymphoid development in hematopoiesis and a means for prospective isolation of LPPs.
This is a preview of subscription content, access via your institution
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Raw sequencing data are available from GEO under accession numbers GSE136341 and GSE136225. Processed data from these analyses are available from https://github.com/LuyiTian/Dach1_analysis_script. The Haemopedia database can be accessed at http://haemosphere.org/. The Immgen database is available from immgen.org.
Code from these analyses is available from https://github.com/LuyiTian/Dach1_analysis_script.
Rothenberg, E. V. Transcriptional control of early T and B cell developmental choices. Annu. Rev. Immunol. 32, 283–321 (2014).
Adolfsson, J. et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential. Cell 121, 295–306 (2005).
Yoshida, T., Ng, S. Y., Zuniga-Pflucker, J. C. & Georgopoulos, K. Early hematopoietic lineage restrictions directed by Ikaros. Nat. Immunol. 7, 382–391 (2006).
Igarashi, H., Gregory, S. C., Yokota, T., Sakaguchi, N. & Kincade, P. W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17, 117–130 (2002).
Berthault, C. et al. Asynchronous lineage priming determines commitment to T cell and B cell lineages in fetal liver. Nat. Immunol. 18, 1139–1149 (2017).
Lai, A. Y., Lin, S. M. & Kondo, M. Heterogeneity of Flt3-expressing multipotent progenitors in mouse bone marrow. J. Immunol. 175, 5016–5023 (2005).
Paul, F. et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 163, 1663–1677 (2015).
Olsson, A. et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature 537, 698–702 (2016).
Nestorowa, S. et al. A single cell resolution map of mouse haematopoietic stem and progenitor cell differentiation. Blood https://doi.org/10.1182/blood-2016-05-716480 (2016).
Giladi, A. et al. Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis. Nat. Cell Biol. 20, 836–846 (2018).
Velten, L. et al. Human haematopoietic stem cell lineage commitment is a continuous process. Nat. Cell Biol. 19, 271–281 (2017).
Notta, F. et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science 351, aab2116 (2016).
Lee, J. et al. Lineage specification of human dendritic cells is marked by IRF8 expression in hematopoietic stem cells and multipotent progenitors. Nat. Immunol. 18, 877–888 (2017).
Jacobsen, S. E. W. & Nerlov, C. Haematopoiesis in the era of advanced single-cell technologies. Nat. Cell Biol. 21, 2–8 (2019).
Naik, S. H. et al. Diverse and heritable lineage imprinting of early haematopoietic progenitors. Nature 496, 229–232 (2013).
Hashimshony, T., Wagner, F., Sher, N. & Yanai, I. CEL-Seq: single-cell RNA-seq by multiplexed linear amplification. Cell Rep. 2, 666–673 (2012).
Hashimshony, T. et al. CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq. Genome Biol. 17, 77 (2016).
Kiselev, V. Y. et al. SC3: consensus clustering of single-cell RNA-seq data. Nat. Methods 14, 483–486 (2017).
Yoshida, H. et al. The cis-regulatory atlas of the mouse immune system. Cell https://doi.org/10.1016/j.cell.2018.12.036 (2019).
Choi, J. et al. Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans. Nucleic Acids Res. 47, D780–D785 (2019).
Chopin, M. et al. Transcription factor PU.1 promotes conventional dendritic cell identity and function via induction of transcriptional regulator DC-SCRIPT. Immunity 50, 77–90 (2019).
Aubrey, B. J. et al. An inducible lentiviral guide RNA platform enables the identification of tumor essential genes and novel tumor promoting mutations in vivo. Cell Rep. https://doi.org/10.1016/j.celrep.2015.02.002 (2015).
Pietras, E. M. et al. Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions. Cell Stem Cell 17, 35–46 (2015).
Dorshkind, K., Höfer, T. H. X., Montecino-Rodriguez, E., Pioli, P. D. & Rodewald, H.-R. Do haematopoietic stem cells age? Nat. Rev. Immunol. https://doi.org/10.1038/s41577-019-0236-2 (2019).
Chung, S. S. & Park, C. Y. Aging, hematopoiesis, and the myelodysplastic syndromes. Hematology Am. Soc. Hematol. Educ. Program 2017, 73–78 (2017).
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477–16 (2018).
De Obaldia, M. E. et al. T cell development requires constraint of the myeloid regulator C/EBP-α by the Notch target and transcriptional repressor Hes1. Nat. Immunol. 14, 1277–1284 (2013).
Metcalf, D., Ng, A., Mifsud, S. & Di Rago, L. Multipotential hematopoietic blast colony-forming cells exhibit delays in self-generation and lineage commitment. Proc. Natl Acad. Sci. USA 107, 16257–16261 (2010).
Nicola, N. A. & Metcalf, D. The Hemopoietic Colony-Stimulating Factors. (Cambridge University Press, 1995).
Haas, S., Trumpp, A. & Milsom, M. D. Causes and consequences of hematopoietic stem cell heterogeneity. Cell Stem Cell 22, 627–638 (2018).
Guilliam, M., Mildner, A. & Yona, S. Developmental and functional heterogeneity of monocytes. Immunity 49, 595–613 (2018).
Laurenti, E. & Göttgens, B. From haematopoietic stem cells to complex differentiation landscapes. Nature 553, 418–426 (2018).
Naik, S. H. Dendritic Cell Development, Lineage Issues and Haematopoiesis at the Single Cell Level. Cell Determination During Hematopoiesis (Nova Press, 2009).
Bell, J. J. & Bhandoola, A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452, 764–767 (2008).
Wada, H. et al. Adult T-cell progenitors retain myeloid potential. Nature 452, 768–772 (2008).
Bhandoola, A., von Boehmer, H., Petrie, H. T. & Zúñiga-Pflücker, J. C. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity 26, 678–689 (2007).
Naik, S. H. Dendritic cell development at a clonal level within a revised ‘continuous’ model of haematopoiesis. Mol. Immunol. 124, 190–197 (2020).
Ji, H. et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467, 338–342 (2010).
Wu, K. et al. DACH1 inhibits transforming growth factor-β signaling through binding Smad4. J. Biol. Chem. 278, 51673–51684 (2003).
Lee, J.-W. et al. DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1. Biochem. Bioph. Res. Co. 420, 91–95 (2012).
Lee, J.-W. et al. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9. Biochem. Bioph. Res. Co. 426, 299–305 (2012).
Chu, V. T. et al. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc. Natl Acad. Sci. USA 113, 12514–12519 (2016).
Kontgen, F., Suss, G., Stewart, C., Steinmetz, M. & Bluethmann, H. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 5, 957–964 (1993).
Lin, D. S. et al. DiSNE movie visualization and assessment of clonal kinetics reveal multiple trajectories of dendritic cell development. Cell Rep. 22, 2557–2566 (2018).
Tian, L. et al. scPipe: a flexible R/Bioconductor preprocessing pipeline for single-cell RNA-sequencing data. PLoS Comput. Biol. 14, e1006361 (2018).
Vallejos, C. A., Marioni, J. C. & Richardson, S. BASiCS: Bayesian analysis of single-cell sequencing. Data. 11, e1004333 (2015).
Lun, A. T. L., Bach, K. & Marioni, J. C. Pooling across cells to normalize single-cell RNA sequencing data with many zero counts. Genome Biol. 17, 75 (2016).
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).
Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184–191 (2016).
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
de Graaf, C. A. et al. Haemopedia: an expression atlas of murine hematopoietic cells. Stem Cell Rep. 7, 571–582 (2016).
We thank the WEHI flow cytometry facility, the Single Cell Open Research Endeavour, S. Wilcox for genomics support and Animal Bioservices for animal husbandry. This work was supported by the National Health & Medical Research Council, with fellowships to S.H.N. (0516782), J.E.B (0637403), C.d.G (1035229), S.L.N. (1155342) and W.S.A (1058344); project grants (1062820, 1124812, 1085765, 1060179, 1122783); a program grant (1113577), the Australian Research Council’s special initiative Stem Cells Australia, an Australian Cancer Research Fund, Victorian State Government Infrastructure Support, Australian Government NHMRC IRIIS and CSL Limited.
The authors declare no competing interests.
Editor recognition statement Jamie D. K. Wilson was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
a, c-Kit-enriched cells from the BM of CD45.1 (WT) and CD45.2 (Cas9-Tg) mice were transduced with lentivirus expressing guide RNAs (Cherry+) that were b) previously validated by western blot to delete Dach1 expression in AML246 cells. These cells were co-injected into sub-lethally irradiated CD45.1/CD45.2 recipient mice and cellular output was analysed at different time-points; c) FACS data from days 20 and 55 is shown. d, For each cell type, the ratio of Cherry+/Cherry– between donor WT and donor Cas9 Tg is shown at multiple times after transplantation as indicated (mean ± S.E.M, 1 experiment). No significant differences in this ratio between WT and Cas9 Tg were observed. Number of mice for each guide RNA and time point is shown.
a, Gating parameters of cells from scRNA-seq in Fig. 4. c-Kit+Sca-1+ LSKs, which contained IL-7R+ lymphoid progenitors, were index sorted from Dach1-GFP reporter mice. b, gating parameters based on the index sorted cells for the indicated HSPC subpopulations used for Fig. 4e–i. c, UMAP with all trajectories inferred by slingshot over cells annotated by transcriptional clusters from Fig. 4a.
Phenotype of progeny from limiting dilution experiments in Fig. 5b. Flt3hi, Flt3int, Dach1-GFP+ and LPPs were isolated and seeded in a) OP9-DL1 cultures to allow T cell generation and b) OP9 cultures to allow B cell generation. Progeny from wells were assessed after 3 weeks and 2 weeks respectively by flow cytometry. One representative well from the row seeded with the lowest dilution of cells is shown. The top row of panel a) and b) is the gating strategy used for all wells.
Extended Data Fig. 5 Flt3hi versus Flt3int separation of LMPPs does not separate myeloid and lymphoid fate.
a, Dach1+, Flt3hi, Flt3int LMPPs and LPPs were sorted from Dach1-GFP reporter mice (CD45.2+) as per Fig. 4a, then transferred into separate groups of sub-lethally irradiated recipients (CD45.1+). b, Myeloid and lymphoid output of donor-derived LMPP fractions is shown by FACS at day 13 and day 28 post transplantation from the blood of recipient mice. Numbers indicate percentage of cells from parent gate. c, Histograms show the percentage of contribution of donor-derived (CD45.2+) cells to differentiated lineages from spleen at day 13 post-transplantation. n = 4 mice from 2 experimental repeats (mean ± S.E.M). Two-tailed unpaired T-test * p < 0.01, ** p < 0.001, *** p < 0.0001. d, Differentiated lineages were also analysed from blood of recipient mice at different time points. Shown is the contribution of donor-derived CD45.1+ cells to each indicated cell type. n = 4 mice from 2 experimental repeats (mean ± S.E.M).
About this article
Cite this article
Amann-Zalcenstein, D., Tian, L., Schreuder, J. et al. A new lymphoid-primed progenitor marked by Dach1 downregulation identified with single cell multi-omics. Nat Immunol 21, 1574–1584 (2020). https://doi.org/10.1038/s41590-020-0799-x